Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma

Table 2 Baseline characteristics of experienced recurrence and non-experienced recurrence patients with hepatocellular carcinoma, after propensity-score matching

Characteristic	ER group	NER group	P value
	n = 25	n = 25
Age (yr)	46.6 ± 8.9	45.7 ± 13.7	0.784
BMI (kg/m2)
< 23	18	16	0.544
≥ 23	7	9
Total bilirubin (mg/dL)	13.2 ± 2.5	15.4 ± 6.4	0.989
Albumin (g/L)	39.3 ± 3.5	40.3 ± 4.7	0.371
ALT (U/L)	39.6 ± 16.9	34.6 ± 12.4	0.232
AST (U/L)	50.4 ± 35.0	47.8 ± 24.9	0.767
Prothrombin time (s)	13.2 ± 2.5	12.7 ± 1.6	0.466
Platelet count (109/L)	141.5 ± 42.0	157.4 ± 64.6	0.308
AFP (ng/mL)
< 400	17	20	0.333
≥ 400	8	5
Tumor size (cm)	6.9 ± 3.0	6.0 ± 2.9	0.164
Liver cirrhosis
Present	18	18	1.000
Absent	7	7
Tumor capsule
Present	7	7	1.000
Absent	18	18
Edmondson grade
I or II	8	12	0.248
III or IV	17	13

AFP: Alpha-fetoprotein; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BMI: Body mass index; ER: Early recurrence; NER: Non-ER.